2,4,6-Triallyloxy-1,3,5-triazin

Liquid; Large Crystals

Colorless liquid; mp = 26-27 deg C; [Sigma-Aldrich MSDS]

175.0 Ų [M+Na]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID8037754]；154.4 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: APCI+; Dataset: TOXCAST; Source Identifier: DTXSID8037754]；154.2 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID8037754]

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]；H411 (100%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]

P264, P270, P273, P301+P317, P330, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 261 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Chemical: 1,3,5-Triazine, 2,4,6-tris(2-propenyloxy)-

1,3,5-Triazine, 2,4,6-tris(2-propen-1-yloxy)- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 1,3,5-Triazine, 2,4,6-tris(2-propen-1-yloxy)- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

Status: Active Update: 07-01-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/15607

2,4,6-Tris(allyloxy)-1,3,5-triazine: Does not have an individual approval but may be used under an appropriate group standard

Causes somnolence in inhalation lethal-concentration studies of rats and dermal lethal-dose studies of rabbits; Causes lachrymation, somnolence, and changes in the structure or function of salivary glands in oral lethal-dose studies of rats; Causes altered sleep time (including change in righting reflex), convulsions, and effects on other transferases in 28-day constant oral studies of rats; [RTECS] May cause irritation; Harmful by ingestion; [Sigma-Aldrich MSDS] See Sodium cyanurate.

Acute Tox. 4 (100%)；Aquatic Chronic 2 (100%)

Acute toxicity (Oral) - Category 4；Specific target organ toxicity - Single exposure - Category 2 (central nervous system)；Specific target organ toxicity - Repeated exposure - Category 2 (central nervous system, liver)

Chemical: 1,3,5-Triazine, 2,4,6-tris(2-propenyloxy)-

1,3,5-Triazine, 2,4,6-tris(2-propen-1-yloxy)- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 1,3,5-Triazine, 2,4,6-tris(2-propen-1-yloxy)- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

Status: Active Update: 07-01-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/15607

2,4,6-Tris(allyloxy)-1,3,5-triazine: Does not have an individual approval but may be used under an appropriate group standard

Synthetic Rubber Manufacturing；Rubber Product Manufacturing；Plastics Material and Resin Manufacturing；Paint and Coating Manufacturing；All Other Chemical Product and Preparation Manufacturing

1,3,5-Triazine, 2,4,6-tris(2-propen-1-yloxy)-: ACTIVE